BPC-157 20 mg10바이알 팩재고 718% 할인
peptideall재고 7

BPC-157 20 mg

조직 복구 연구 펩타이드

Buy BPC-157 in Australia for research applications. Lab-tested, ≥99% purity, Australian-shipped.

Strength
용량
20mg / 바이알
제형
동결건조 분말
팩
10바이알 팩

연구 전용. 이 화합물은 체외 연구 및 실험실 용도로만 판매되며, 인체 섭취나 치료 목적 사용을 의도하지 않습니다. 구매함으로써 귀하가 자격을 갖춘 연구자이며 당사의 전체 면책 조항에 동의하는 것으로 간주됩니다.

₩275,092 KRW
18% 할인
10바이알 팩
정가 ₩335,478 KRW
10바이알 팩으로 판매

7팩만 남음

🧪실험실 검증
✓제3자 검사
⚡빠른 전 세계 배송
🔒안전한 카드 결제
개요

Body Protective Compound 157은 합성 펩타이드 단편입니다. 조직 복구 경로, 혈관신생 기전, 장 점막 온전성에 대한 영향이 연구 모델에서 검토되었습니다.

BPC-157 (Body Protection Compound 157) is a synthetic 15-amino-acid peptide derived from a protective protein originally identified in human gastric juice. It is one of the most extensively studied research peptides in tissue-repair literature, with published work spanning tendon, ligament, gastrointestinal, and vascular models. Quantum Labs supplies BPC-157 as a lyophilised powder in sealed 5 mg vials for research applications.

Australian researchers source BPC-157 through three channels: compounded prescription supply via registered pharmacies, imported reference standards, and research-grade peptide suppliers. Our material falls in the third category — supplied without therapeutic representation, certified to ≥99% HPLC purity, and shipped domestically from Australian stock. Every batch ships with identity confirmation by mass spectrometry available on request.

BPC-157 is most commonly the subject of research stacked with TB-500 (thymosin β-4 fragment), where the combination is studied for synergistic effects on tissue remodelling pathways. We supply both compounds individually and as a pre-portioned BPC-157 + TB-500 research stack.

작용 기전

연구는 BPC-157이 산화질소 경로 및 성장인자 신호와 상호작용하며, 연구 대상의 조직 복구 지표와 관련됨을 시사합니다.

실험실 보고서

순도 규격 ≥99%에 대해 HPLC로 검증되었습니다. 인증된 제3자 실험실에서 독립적으로 시험합니다.

Research applications

Peer-reviewed work on BPC-157 spans models of tendon and ligament healing, gut-barrier function, inflammatory bowel models, and vascular regeneration. Pentadecapeptide BPC-157 has shown protective effects across multiple organ systems in pre-clinical rodent studies, with proposed mechanisms involving the nitric oxide pathway, VEGF expression, and growth-hormone receptor modulation.

The compound is structurally distinct from native gastric BPC and is stable in human gastric juice — a property that has driven research interest in oral as well as injected delivery formats.

Storage and handling

Lyophilised BPC-157 is stable at room temperature for several weeks and at 2-8°C for several months in unopened sealed vials. Once reconstituted with bacteriostatic water, the working solution is typically stored at 2-8°C and used within 30 days. Avoid freeze-thaw cycles, which can degrade peptide integrity.

Bacteriostatic water for reconstitution is available as a separate research supply — see our Bacteriostatic Water listing.

연구자 FAQ

BPC-157 — 자주 묻는 질문

Is BPC-157 legal in Australia?

BPC-157 occupies a regulatory grey zone in Australia. The Therapeutic Goods Administration (TGA) has restricted compounded BPC-157 for human therapeutic supply, but the compound remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies BPC-157 for research use only — not for human consumption.

What is BPC-157 used for in research?

Published research on BPC-157 spans tissue repair, tendon and ligament healing models, gastrointestinal protection studies, inflammatory bowel models, and vascular regeneration. It is one of the most well-cited tissue-repair peptides in pre-clinical literature. Quantum Labs supplies this compound for laboratory and pre-clinical research use only. It is not represented for human therapeutic use, and questions about clinical dosing, treatment effects, or personal use should be directed to a qualified medical practitioner.

What is the typical BPC-157 research dosage?

Published rodent studies have used wide dose ranges from approximately 10 μg/kg to 250 μg/kg, with the most common doses in tendon-healing models falling around 10-20 μg/kg. Human dosing is not established, as BPC-157 is not an approved therapeutic. Researchers should consult primary literature for protocol-specific guidance.

What are the documented side effects of BPC-157?

BPC-157 has shown a wide tolerability margin in pre-clinical rodent studies, with no significant toxicity reported even at doses far above the therapeutic range under study. Long-term human safety data is not available — BPC-157 has not undergone human regulatory trials. Quantum Labs supplies this compound for laboratory and pre-clinical research use only. It is not represented for human therapeutic use, and questions about clinical dosing, treatment effects, or personal use should be directed to a qualified medical practitioner.

Can BPC-157 be taken orally?

Research interest in oral BPC-157 stems from the parent molecule's natural origin in gastric juice — making it unusually stable in the gastrointestinal tract for a peptide. Both injected and oral delivery have been used in pre-clinical study designs. Quantum Labs supplies the lyophilised powder; researchers determine the appropriate delivery format for their study.

What's the difference between BPC-157 and TB-500?

BPC-157 is a 15-amino-acid synthetic peptide derived from a gastric protective protein, while TB-500 is a 17-amino-acid fragment of the natural protein thymosin β-4. Both are studied in tissue-repair research and are often used together. BPC-157 research focuses on vascular regeneration and nitric oxide pathway modulation; TB-500 research focuses on actin binding and cell migration.

Where can I buy BPC-157 in Australia?

Quantum Labs ships BPC-157 from Australian stock to verified researchers. Material is HPLC-verified ≥99% purity, third-party tested, and supplied for research use only. Domestic delivery is typically 2-5 business days from payment confirmation.

더 읽어보기

BPC-157 관련 가이드

관련 화합물

연구자들이 함께 살펴보는 항목